An Official Website of the United States Government
Company Information:
Name:
BIOPTIGEN, INC.
Address:
BPX 13569
DURHAM, NC 27709-
DURHAM, NC 27709-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Ophthalmic Optical Coherence Tomography
Award Year / Program / Phase:
2006 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Eric L. Buckland
Award Amount:
$747,622.00
Abstract:
DESCRIPTION (provided by applicant): This Phase II Small Business Innovative Research application proposes to dramatically expand the commercial availability of optical coherence tomography (OCT) technology for pre-clinical human and animal research applications by commercializing Fourier-domain OCT… More
Full Range Spectral Domain Anterior Segment OCT Scanner
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Eric Buckland
Award Amount:
$154,993.00
Abstract:
DESCRIPTION (provided by applicant): In this Phase I Small Business Innovative Research application, Bioptigen Inc. proposes to prototype a portable, handheld cornea and anterior segment optical coherence tomography (CAS-OCT) scanner for use in clinical an
d applied research applications. OCT is a… More
Robust Wide-Angle Spectral Domain OCT Arthroscope for Operative Imaging and Guida
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$201,230.00
Abstract:
DESCRIPTION (provided by applicant): This Phase I Small Business Innovative Research application proposes to develop a robust spectral domain optical coherence tomography (SDOCT) system suitable for combined diagnosis and treatment monitoring of osteoarthr
itis. Osteoarthritis is reaching epidemic… More
Bioptigen SBIR Phase I resubmittal: Pediatric OCT
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Bradley A. Bower
Award Amount:
$150,842.00
Abstract:
DESCRIPTION (provided by applicant): This Phase I Small Business Innovative Research application proposes to introduce for the first time to commercial availability a spectral domain optical coherence tomography (SDOCT) system specifically designed for ped
iatric patients. OCT is a well-established… More
Extended Depth SDOCT Imaging
Award Year / Program / Phase:
2010 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Eric L. Buckland
Award Amount:
$1,565,568.00
Abstract:
DESCRIPTION (provided by applicant): In this Phase II Small Business Innovation Research application, Bioptigen, Inc. proposes to commercialize a deep imaging spectral domain optical coherence tomography (DI-SDOCT) imaging system that incorporates technolo
gy proven during the Phase I period to… More
Pediatric Spectral Domain Optical Coherence Tomography
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Bradley A. Bower – 919-314-5500
Award Amount:
$2,757,938.00
Abstract:
DESCRIPTION (provided by applicant): Acquiring diagnostic images of the retina in children is necessary to the prevention and treatment of pediatric eye disease, but it is often difficult due to the large range of eye shapes and sizes from preemies to older children and the inability of most… More
Aspheric SDOCT Imaging System for Dry Eye and Cornea Diagnostics
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Eric L. Buckland – 919-314-5502
Award Amount:
$288,530.00
Abstract:
DESCRIPTION (provided by applicant): Dry Eye disease is an affliction that impacts as many much as 20% of the U.S. population over age 50, and is even more prevalent in the Asia Pacific. Dry eye therapies are currently a 1.7B market, growing at 10% annually. Treatment is primary palliative,… More